![Cara Therapeutics logo](/news-release/logo/311292/0/311292.jpg?lastModified=12%2F09%2F2016%2023%3A24%3A14&size=2)
Cara Therapeutics Announces Proposed Offering of Common Stock
27 juil. 2015 16h20 HE
|
Cara Therapeutics
SHELTON, Conn., July 27, 2015 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...
![Cara Therapeutics logo](/news-release/logo/311292/0/311292.jpg?lastModified=12%2F09%2F2016%2023%3A24%3A14&size=2)
Cara Therapeutics Announces Positive Results From Phase 2 Trial in Uremic Pruritus
23 juil. 2015 07h00 HE
|
Cara Therapeutics
Novel peripheral kappa opioid I.V. CR845 achieved statistically-significant results on primary endpoint of reducing worst itch intensity
Trial demonstrated statistically significant results on...
![Cara Therapeutics logo](/news-release/logo/311292/0/311292.jpg?lastModified=12%2F09%2F2016%2023%3A24%3A14&size=2)
Cara Therapeutics Completes Enrollment of Phase 2 Trial of I.V. CR845 in Uremic Pruritus
23 juin 2015 08h00 HE
|
Cara Therapeutics
Top-line data expected in early 3Q'15
SHELTON, Conn., June 23, 2015 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and...
![Cara Therapeutics logo](/news-release/logo/311292/0/311292.jpg?lastModified=12%2F09%2F2016%2023%3A24%3A14&size=2)
Cara Therapeutics to Sponsor Symposium and Present Poster at the College on Problems of Drug Dependence 77th Annual Meeting
10 juin 2015 08h00 HE
|
Cara Therapeutics
SHELTON, Conn., June 10, 2015 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate...
![Cara Therapeutics logo](/news-release/logo/311292/0/311292.jpg?lastModified=12%2F09%2F2016%2023%3A24%3A14&size=2)
Cara Therapeutics to Present at the 2015 International Conference on Opioids
05 juin 2015 08h00 HE
|
Cara Therapeutics
SHELTON, Conn., June 5, 2015 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate...
![Cara Therapeutics logo](/news-release/logo/311292/0/311292.jpg?lastModified=12%2F09%2F2016%2023%3A24%3A14&size=2)
Cara Therapeutics Reports First Quarter 2015 Financial Results
12 mai 2015 16h01 HE
|
Cara Therapeutics
– End-of-Phase 2 Meeting With FDA Informs Phase 3 Clinical Development Program for Novel Kappa Opioid I.V. CR845 –
– Conference Call Today at 4:30 p.m. ET –
SHELTON,...
![Cara Therapeutics logo](/news-release/logo/311292/0/311292.jpg?lastModified=12%2F09%2F2016%2023%3A24%3A14&size=2)
Cara Therapeutics to Present at American Pain Society 34th Annual Scientific Meeting
06 mai 2015 08h00 HE
|
Cara Therapeutics
Pain experts to discuss kappa opioid receptor agonists and latest developments in pain management
Company to present positive data from Phase 2, human abuse liability studies of I.V. CR845...
![Cara Therapeutics logo](/news-release/logo/311292/0/311292.jpg?lastModified=12%2F09%2F2016%2023%3A24%3A14&size=2)
Cara Therapeutics to Announce First Quarter 2015 Financial Results on May 12, 2015
05 mai 2015 16h30 HE
|
Cara Therapeutics
SHELTON, Conn., May 5, 2015 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate...
![Cara Therapeutics logo](/news-release/logo/311292/0/311292.jpg?lastModified=12%2F09%2F2016%2023%3A24%3A14&size=2)
Cara Therapeutics to Present at 3rd Conference on the Therapeutic Potential of Kappa Opioids
15 avr. 2015 08h00 HE
|
Cara Therapeutics
Company to present data from human abuse liability (HAL) study of I.V. CR845
SHELTON, Conn., April 15, 2015 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology...
![Cara Therapeutics logo](/news-release/logo/311292/0/311292.jpg?lastModified=12%2F09%2F2016%2023%3A24%3A14&size=2)
Cara Therapeutics to Webcast Presentation at 14th Annual Needham Healthcare Conference
07 avr. 2015 08h00 HE
|
Cara Therapeutics
SHELTON, Conn., April 7, 2015 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate...